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BACKGROUND፡ The marked genome plasticity of diarrheagenic 
Escherichia coli promotes emergence of pathotypes displaying 
unique phenotypic and genotypic resistance. This study examined 
phenotypic and genotypic antibiotic resistant diarrheagenic 
Escherichia coli pathotypes among children in Nairobi City, 
Kenya.  
METHODS: In a cross-sectional study, diarrheagenic 
Escherichia coli pathotypes were isolated from stool samples and 
their  phenotypic and genotypic resistance against eight 
antimicrobial agents assayed.  
RESULTS: Diarrheagenic Escherichia coli was detected in 
136(36.4%) children. Most of diarrheagenic Escherichia coli that 
were resistant to  ampicillin, ceftriaxone, streptomycin, 
gentamycin, ciprofloxacin, chloramphenicol, erythromycin and 
tetracycline, harbored citm,  bla CMY, aadA1,  aac(3)-IV, qnr, 
catA, ere(A) and tet(A) corresponding resistant genes. 
CONCLUSION: Antimicrobial-resistant genes are highly 
prevalent among phenotypic resistant ETEC pathotypes 
indicating a possibility of horizontal gene transfer in spreading 
antibiotic resistant genes among E. coli pathotypes.  
KEYWORDS: Phenotypic, Genotypic, Antibiotic Resistant, 
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There is a worldwide concern about the rise and 
spread of bacterial resistance to commonly 
prescribed antimicrobial agents.  A United 
Nation’s report revealed that antibiotic 
resistance cause at least  700,000 deaths globally 
a year currently, and the figure could increase up 
to 10  million deaths globally by 2050, without a 
sustained effort to contain antimicrobial 
resistance (1). Meanwhile, the World Health 
Organization forewarns the severity of antibiotic 
resistance, stating that “it threatens the 
achievements of modern medicine, a post-
antibiotic era, in which common infections and 
minor injuries can kill, is a very real possibility 
for the 21st century” (2).  In this regard, 
programs for monitoring antimicrobial 
resistance have been established in many 
countries worldwide, including the antimicrobial 
resistance surveillance program of the National 
Public Health Laboratories (NPHLs) and 
Kenyan Medical Research Institute (KEMRI) in 
Kenya (2).   
Diarrheal illnesses are a severe public 
health problem and a major cause of morbidity 
and mortality in infants and young children 
globally (3).  Diarrhegenic E. coli involved in 
diarrheal diseases is one of the most important 
of the various etiological agents of diarrhea (3).  
In Kenya, over 15% infectious diarrhea cases 
present in health facilities (4,5) but only half of 
health facilities are able to detect and diagnose a 
pathogen, which may be due to lack of or 
inadequate diagnostic capacity (6).  Thus, 
indiscriminate antibiotic treatment is crucial for 
weak individuals with severe dysentery and non-
dysentery infection without secondary criteria 
for bacterial infection (4,7) increasing selection 
pressure of antibiotic resistant strains and 
decreasing the effectiveness of antibiotics (8).  
With an exception of few studies (9-12) previous 
studies reported phenotypic resistance without 
assessing genetic changes associated with 
resistance in diarrhegenic and uropathogenic 
Escherichia coli to commonly prescribed 
antibiotics in Kenya (13-20). Genetic changes 
associated with phenotypic resistance to 
quinolones, gentamycin, tetracycline, 
Sulfonamide, Trimethoprim and beta-lactams 
has been investigated in diarrhegenic 
Escherichia coli (10-12) while phenotypic 
expression of quinolones and beta-lactams 
resistant genes have been investigated in 
uropathogenic Escherichia coli (9) in kenya.  To 
our knowledge, no study investigated 
erythromycin, chloramphenicol and 
streptomycin resistant genes in diarrhegenic 
Escherichia coli isolated from humans in Kenya. 
According to the group of virulence 
determinants acquired, specific combinations 
were formed determining the currently known 
diarrheagenic Escherichia coli pathotypes and 
comprises of six groups:  enteropathogenic E. 
coli (EPEC), enterohemorrhagic (Shiga toxin-
producing) E. coli (EHEC/STEC), 
enteroaggregative E. coli (EAEC), 
enterotoxigenic E. coli (ETEC), enteroinvasive 
E. coli (EIEC) and diffuse adhering/diffusely 
adherent E. coli (DAEC). Until now, there is 
limited information about the distribution of 
phenotypic and genotypic antibiotic resistance 
across these Escherichia coli pathotypes in 
humans (21-23).  A previous study in Northern 
Iran (Tehran City), indicated high phenotypic 
resistance frequency of STEC in a population of 
EPEC, STEC, EAEC and ETEC infected 
diarrheic children (22) while a study in Western 
Iran reported high phenotypic resistant rates of 
EHEC in a population of EPEC, STEC and 
EHEC infected children (23) suggesting that 
Escherichia coli phenotypic resistance is highly 
polymorphic attributed to genome plasticity of 
E. coli accelerating emergence of pathotypes 
displaying unique antibiotic phenotypic 
resistance (24-26).  In India, EPEC were found 
to harbor higher number of antibiotic resistant 
genes in a population of EAEC, ETEC, EIEC 
and EHEC isolates from diarrheic children (21).  
Since there are significant differences in 
antibiotic use between countries indicating that 
some countries are probably overusing 
antibiotics (27,28) which may drive 
development of antimicrobial resistance in 
genetically and geographically diverse 
diarrheagenic Escherichia coli pathotypes (8,24-
26), to our knowledge, no study has determined 
rates of antimicrobial resistant genes 
concurrently in EAEC, ETEC, EIEC and EHEC 
clinical isolates from humans in Kenya. This 
study, therefore, determined phenotypic and 
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genotypic antibiotic resistance of diarrheagenic 
Escherichia coli pathotypes isolated from 




Study site, design and population: Detailed 
description of the study site, design and 
population is presented here (13).  Briefly, this 
was a cross-sectional study targeting diarrheic 
children <5 years, seeking treatment for diarrhea 
at Mbagathi Hospital, Nairobi City, Kenya. A 
total of 374 children with diarrhea were enrolled 
into the study. Diarrhea was defined according 
to World Health Organization (WHO) guidelines 
(29).  Demographic and clinical information of 
these study participants were collected using a 
questionnaire.  Stool microbiology tests were 
performed within two hours of sample 
collection.  Stool samples of children who had 
received antibiotics were excluded from the 
study.   
 
Bacteriological procedures: Identification of 
E.coli species was performed by following the 
WHO recommendations (30). Briefly, stool 
samples were plated on MacConckey Agar 
(MCA), Xylose lysine Deoxycholate (XLD), and 
sorbitol MacConkey agar (SMAC) and 
incubated at 37°C overnight. Complete 
biochemical identification was used to confirm 
the identity of the cultured organism. DNA from 
cultured E. coli isolates was extracted using 
QIAamp® DNA Mini Kit (QIAGEN GmbH, 
Hilden, Germany) according to the 
manufacturer’s recommendations.  Conventional 
polymerase chain reaction (PCR) assay was used 
to detect diarrhegenic E. coli  pathotypes based 
on specific virulence genes as previously 
described (13). 
Phenotypic Antimicrobial Resistance: 
Antimicrobial susceptibility testing was carried 
out on Muller-Hinton agar with antibiotic discs 
by the disc diffusion method based on guidelines 
adopted from Clinical and Laboratory Standards 
Institute (CLSI) (31).  Antibiotics discs of 
ampicillin, ceftriaxone, streptomycin, 
gentamycin, ciprofloxacin, chloramphenicol, 
erythromycin and tetracycline were tested. 
Detection of antibiotic resistant genes: DNA 
from cultured isolates was extracted using 
QIAamp® DNA Mini Kit (QIAGEN GmbH, 
Hilden, Germany) according to the 
manufacturer’s recommendations. The isolates 
were grouped on the basis of resistance 
phenotype and determined for the presence of 
corresponding antibiotic resistance genes.  The 
presence of resistance genes to ampicillin: citm, 
ceftriaxone: bla CMY, streptomycin: aadA1, 
gentamycin: aac(3)-IV, ciprofloxacin: qnr, 
chloramphenicol: catA1, erythromycin: ere(A) 
and tetracycline: tet(A) were detected by PCR. 
The primers sequences and the amplicon sizes 
are listed in Table 1. Amplified samples were 
analyzed by electrophoresis in 1.5% agarose gel 
and stained by ethidium bromide.  
 
Data analysis: Statistical analyses were 
performed using SPSS version 19.0 for 
Windows (IBM SPSS Statistics for Windows, 
Version 19.0. Armonk, NY: IBM Corp.).  
Descriptive statistics; namely, frequencies and 
percentages were used to present demographic 
and clinical data, and phenotypic and genotypic 
frequencies.  
 
Ethical considerations: Ethical approval for 
this study was granted by Kenyatta National 
Hospital/University of Nairobi (KNH-UoN) 
Ethics and Research Committee and was 
conducted according to Helsinki declarations 
(32).  Written informed consent was sought from 
either parent or guardian of each child.  
Diarrheic children were treated by clinicians 
according to the World Health Organization 
(WHO) guidelines for treatment of diarrhea in 
children (29).  All study participants' 
information and test results were confidentially 
kept.  The results of bacterial cultures were used 
in clinical management of study participants. 
 
RESULTS 
In this study, a total of 374 children were 
recruited; diarrheagenic Escherichia coli was 
successfully isolated in 136(36.4%) children. 
The demographic and clinical information of the 
136 children infected with diarrheagenic 
Escherichia coli is presented in Table 2.  Age 
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distribution showed that, 63(46.3%) were within 
the age group between 1 and 36 months, and 73 
(53.7%) children were between 37 and 60 
months.  The overall gender distribution was 
55(40.4%) females and 81(59.6%) males.  
Guardians of 126(92.6%) and 10(7.4%) children 
reported using piped and borehole water, 
respectively.  In addition, 69(50.7%) reported 
treating drinking water.   
Temperature of <38.0°C and ≥ 38.0°C was 
recorded in 21(15.4%) and 115(84.6%) children, 
respectively.  In this study, 87(64.0%), 
24(17.6%) and 25(18.4%), respectively, reported 
having diarrhea for 1-3, 4-6 and ≥7 days.  
Vomiting was reported in 127(93.4%), fever in 
118(86.8%), abdominal cramp in 129(94.9%), 
headache in 33 (24.3%), nausea in 44 (32.4%), 
and appetite loss in 131(96.3%) children.  
Clinical diagnosis of dehydration revealed that 
116(85.3%) had sunken eyeballs, 47(34.6%) 
children had dry tongue and 69(50.7%) had 
reduced skin elasticity. Diarrheagenic 
Escherichia coli  pathotyping showed that 
78(57.4%), 2(1.5%), 15(11.0%) and 38(27.9%) 
were infected with EAEC, EPEC, ETEC and 
EIEC pure strains, while mixed pathotype 
infection was detected in 2(1.5%) children for 
EAEC/ETEC and 1(0.7%) child for 
EAEC/EPEC/ETEC.   
 
Table 1: Primers used for detection of antimicrobial resistant genes 
 
 
Antibiotic type Antibiotic resistant gene Primer sequence Amplicon 
size 
Ampicillin citm F: TGG CCA GAA CTG ACA GGC AAA 
R: TTT CTC CTG AAC GTG GCT GGC 
462 
Ceftriaxone β-lactamase encoding 




















Chloramphenicol Acetyltransferases (catA1) F: AGTTGCTCAATGTACCTATAACC 
R: TTGTAATTCATTAAGCATTCTGCC 
547 











Primers used in the current study were adopted from previous studies (40, 41). 
 
Antimicrobial resistant phenotypes and genes 
of diarrheagenic Escherichia coli: 
Antimicrobial resistant phenotypes and genes of 
diarrheagenic E. coli are presented in Table 3.  A 
total of 71(53.4%), 17(12.8), 89(66.9), 91(68.4), 
40(30.1), 87(65.4), 12(9.0) and 111(83.5) 
diarrheagenic Escherichia coli isolates identified 
as phenotypic resistant to ampicillin, 
ceftriaxone, streptomycin, gentamycin, 
ciprofloxacin, chloramphenicol, erythromycin 
and tetracycline, respectively, 70(98.6%), 
15(88.2%), 83(93.3), 60(65.9%), 38(95.0%), 
85(87.6%), 11(91.7%) and 102(91.9%) 
contained citm,  bla CMY, aadA1,  aac(3)-IV, 
qnrA1, catA, ere(A) and tet(A) corresponding 






Table 2: Demographic and clinical information 
of study participants 
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Characteristics  Number (%) 
Age in months  
   1-36 63(46.3) 
   37-60 73(53.7) 
Gender  
   Female 55(40.4) 
   Male 81(59.6) 
Source of water  
   Piped water 126(92.6) 
   Borehole 10(7.4) 
Water treatment 69(50.7) 
Body temperature  
   <38.0 21(15.4) 
   ≥ 38.0 115(84.6) 
Duration of diarrhea  
   1-3 87(64.0) 
   4-6 24(17.6) 
   ≥7 25(18.4) 
Symptoms  
   Vomiting 127(93.4) 
   Fever 118(86.8) 
   Abdominal cramp 129(94.9) 
   Headache 33(24.3) 
   Nausea 44(32.4) 
   Appetite loss 131(96.3) 
   Sunken eyeball 116(85.3) 
   Dry tongue 47(34.6) 
   Reduced skin elasticity 69(50.7) 
E. coli pathotype  
     EAEC 78(57.4) 
     EPEC 2(1.5) 
     ETEC 15(11.0) 
     EIEC 38(27.9) 
     EAEC/ETEC 2(1.5) 






Phenotypic and genotypic antibiotic 
resistance of E. coli pathotypes: Phenotypic 
resistant rate of ampicillin was 53.8%, 100.0%, 
40.0% and 55.3% while ceftriaxone resistance 
rate was reported 10.3%, 0.0%, 13.3% and 
18.4% in EAEC, EIEC, EPEC and ETEC 
pathotypes, respectively.  Streptomycin 
resistance rate was 67.9%, 100.0%, 66.7%, and 
63.2% while that of gentamycin was 65.4%, 
100.0%, 60.0%, and 76.3% in EAEC, EIEC, 
EPEC and ETEC pathotypes, respectively. 
Ciprofloxacin resistant rates were 25.6%, 50.0%, 
20.0%, and 42.1% while chloramphenicol 
resistant rates were 59.0%; 50.0%, 66.7% and 
78.9%, 25.6%, 50.0%, 20.0%, and 42.1%, in 
EAEC, EIEC, EPEC and ETEC pathotypes, 
respectively.   Erythromycin resistance rate was 
9.0%, 50.0%, 0.0% and 10.5% of while 
tetracycline resistance rate was 8.8%, 100.0%, 
93.3% and 84.2% EAEC, EIEC, EPEC and 
ETEC pathotypes, respectively.  The phenotypic 
resistant isolates were assayed for the presence 
of resistant genes. Citm gene was detected in 
52.6%%, 100.0%%, 40.0%, and 55.3%  while 
bla CMY was detected in 10.3%, 0.0%, 13.3%, 
and 13.2%in EAEC, EIEC, EPEC and ETEC 
pathotypes, respectively. The rate of aadA1 was 
61.5%, 100.0%, 66.7% and 60.5% while that of 
aac(3)-IV  was 39.7%, 0.0%, 60.0% and 52.6% 
in EAEC, EIEC, EPEC and ETEC pathotypes, 
respectively.  Prevalence of qnrA1 was 24.4%, 
50.0%, 20.0% and 39.5% while that of catA was 
60.3%, 50.0%, 66.7% and 71.1% in EAEC, 
EIEC, EPEC and ETEC pathotypes, 
respectively.  Prevalence of ere(A)  was 9.0%, 
0.0%, 0.0% and 10.5% while that of tet(A) was 
71.8%, 50.0%, 93.3% and 81.6%  in EAEC, 
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Table 3: Antimicrobial resistant phenotypes and genes of diarrheagenic Escherichia coli  
 
Data are presented as number and proportions (%) of study participants. bla SHV, β-lactamase encoding penicillin 
resistance. bla CMY,  β-lactamase encoding cephalosporin resistance. aadA1, adenylyl transferases. aac(3)-IV, 
aminoglycoside acetyltransferases. qnr, quinolone resistance protein. catA1, acetyltransferases. ere(A), erythromycin 
esterase. tet(A), efflux pump resistance. 
Table 4: Phenotypic and genotypic antibiotic resistance of E. coli pathotypes 
 
Antibiotic Resistance EAEC (n=78) EIEC (n=2) EPEC (n=15) ETEC (n=38) 
Phenotypic resistance     
     Ampicillin 42(53.8) 2(100.0) 6(40.0) 21(55.3) 
     Ceftriaxone 8(10.3) 0(0.0) 2(13.3) 7(18.4) 
     Streptomycin 53(67.9) 2(100.0) 10(66.7) 24(63.2) 
     Gentamycin 51(65.4) 2(100.0) 9(60.0) 29(76.3) 
     Ciprofloxacin 20(25.6) 1(50.0) 3(20.0) 16(42.1) 
     Chloramphenicol 46(59.0) 1(50.0) 10(66.7) 30(78.9) 
     Erythromycin 7(9.0) 1(50.0) 0(0.0)  4(10.5) 
     Tetracycline 63(8.8) 2(100.0) 14(93.3) 32(84.2) 
Genotypic resistance     
     citm 41(52.6) 2(100.0) 6(40.0) 21(55.3) 
     bla CMY 8(10.3) 0(0.0) 2(13.3) 5(13.2) 
     aadA1 48(61.5) 2(100.0) 10(66.7) 23(60.5) 
     aac(3)-IV 31(39.7) 0(0.0) 9(60.0) 20(52.6) 
     qnr 19(24.4) 1(50.0) 3(20.0) 15(39.5) 
     catA1 47(60.3) 1(50.0) 10(66.7) 27(71.1) 
     ere(A) 7(9.0) 0(0.0) 0(0.0) 4(10.5) 
     tet(A) 56(71.8) 1(50.0) 14(93.3) 31(81.6) 
Data are presented as number and proportions (%) of study participants. aadA1, adenylyl transferases. aac(3)-IV, 
aminoglycoside acetyltransferases. qnr, quinolone resistance protein. catA1, acetyltransferases. ere(A), erythromycin 
esterase. tet(A), efflux pump resistance.  
 
DISCUSSION 
Diarrheagenic Escherichia coli is a major 
etiology of bacterial diarrhea globally (3).  Even 
though antibiotics have been used to control E. 
coli  infections, the marked genome plasticity of 
E. coli has allowed the emergence of pathotypes 
displaying unique virulence and antimicrobial 
resistance genes (33). Furthermore, the 
prevalence of E. coli pathotypes and their 
antimicrobial resistance differ geographically 
(25). Thus, assessing the diversity and 
distribution of antibiotic resistant genes in a 
population of E. coli pathotypes represents a 
more detailed and potentially useful additional 
tool for improving our understanding of 
antimicrobial resistance epidemiology. 
Dysentery, non-dysentery infections and 
other clinical complications of infections are 
serious among Kenyans presenting in health 
facilities without capacity to diagnose and detect 
bacterial pathogens, compelling clinicians to 
consider the provision of empirical antibiotic 
therapy (4,7).  In addition, Kenya has no 
Antibiotic Resistant phenotype (n) Resistant Gene Number (%) 
Ampicillin 71(53.4) citm 70 (98.6) 
Ceftriaxone  17(12.8) bla CMY 15 (88.2) 
Streptomycin 89(66.9) aadA1 83 (93.3) 
Gentamycin 91(68.4) aac(3)-IV 60 (65.9) 
Ciprofloxacin 40(30.1) qnr 38 (95) 
Chloramphenicol 87(65.4) catA1 85 (87.6) 
Erythromycin 12(9.0) ere(A) 11 (91.7) 
Tetracycline 111(83.5) tet(A) 102 (91.9) 
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legislation for controlling antibiotic use in 
animals; further pressure is applied on antibiotic 
use as growth promoters and not for the 
treatment of infections of farm animals (34). At 
the same time, although the purchase of 
antibiotics from retail pharmacies without a 
prescription is forbidden by Kenya’s Pharmacy 
and Poisons Board (35), over-the-counter sale of 
antimicrobials without a prescription is possible 
and may aggravate antibiotic resistance and 
spread resistant strains (36,37).  Because 
inappropriate antibiotic use selects antibiotic 
resistance, it was not surprising that our study 
found high phenotypic antibiotic resistance rates 
to ampicillin, streptomycin, gentamycin, 
ciprofloxacin, chloramphenicol and tetracycline 
suggesting that these six drugs should not be 
used as a first-line therapeutic drug for 
diarrheagenic Escherichia coli.  After 
phenotypic screening, genes associated with 
antimicrobial resistance were determined by 
polymerase chain reaction (PCR).  In this study, 
resistance genes detected were citm, bla CMY, 
aadA1, aac(3)-IV, qnrA1, catA, ere(A) and tet(A) 
for ampicillin, ceftriaxone, streptomycin, 
gentamycin, ciprofloxacin, chloramphenicol, 
erythromycin and tetracycline, respectively.  
Interestingly, a proportion of phenotypic 
resistant diarrheagenic Escherichia coli did not 
harbor these antimicrobial resistant genes while 
the isolates were fully resistant, suggesting a 
possibility of existence of other antimicrobial 
resistant genes and mechanisms of causing 
antimicrobial resistance such as efflux pumps.  
This is the first study to investigate citm, aadA1, 
aac(3)-IV, catA, and ere(A) in diarrheagenic 
Escherichia coli samples isolated from human 
beings in Kenya.  The observations of the  
present study are similar to previous studies in 
Kenya that detected  blaCMY, qnrA and qnrB  
(10,11),  and tetA in  E. coli isolated from stool 
samples (12) and bla CMY, qnrA and qnrB in E. 
coli isolated from urine samples (9).  In addition, 
these observations are consistent with previous 
studies that detected aadA1, tetA, qnr, aac(3)-IV, 
citm and cat1 for streptomycin, tetracycline, 
ciprofloxacin, gentamycin, ampicillin and 
chloramphenicol resistance genes, respectively, 
in E. coli isolated from stool samples among 
pediatric patients younger than five years in Iran 
(38).   Possible explanation for the persistence of 
resistance to these antibiotics includes the 
frequent co-existence of resistant genes on large 
transferable plasmids (39) after a possible 
antibiotic selection pressure (8).  Hence, 
widespread public health education and 
supervision of the sales and prescription of 
antibiotics in retail pharmacies and hospitals are 
needed, to preserve the effectiveness of 
remaining antibiotics. 
To our knowledge, the present study is the 
first in Kenya that investigated simultaneously 
the presence of phenotypic and genotypic 
resistance in four diarrheagenic Escherichia coli 
(EAEC, EIEC, EPEC and ETEC) pathotypes.  In 
our study, there was a high incidence of 
phenotypic resistant isolates of ETEC to 
ampicillin, gentamycin, ciprofloxacin, 
chloramphenicol and tetracycline.  A study in 
Northern Iran (Tehran City) that concurrently 
isolated EPEC, STEC, EAEC and ETEC from 
patients with diarrhea indicated high phenotypic 
resistance frequencies of STEC to ampicillin, 
tetracycline, streptomycin and chloramphenicol 
(22), while another study in Western Iran that 
concurrently isolated  EPEC, STEC and EHEC 
from diarrheic patients revealed high phenotypic 
resistant rates in EHEC to ampicillin, 
tetracycline and ciprofloxacin (23).  Consistent 
with phenotypic resistance, the frequency of 
Ampicillin (citm), gentamycin (aac(3)-IV),  
ciprofloxacin (qnr), chloramphenicol (catA), 
tetracycline (tetA) resistant genes was high in 
ETEC. This suggest that ETEC is a reservoir of 
antimicrobial resistant genes which can easily 
get transferred among the diarrehgenic E. coli 
community via horizontal gene transfer. This 
hypothesis is rainforced  by the presence of 
EAEC/ETEC and EAEC/EPEC/ETEC hybrids 
in this study (24) thus exhibiting the 
phenomenon of antibiotic resistance genes (citm, 
blaCMY, aadA1, aac3, qnr, catA, ere(A), tetA) 
detected in EAEC, EIEC and EPEC isolates in 
this study.  A study in India that concurrently 
isolated ETEC, EIEC, EAEC and EHEC from 
adults and children patients detected tetA in 
EIEC, aac3 in ETEC, EIEC and EAEC, catA in 
ETEC,  EIEC and EAEC, aad in ETEC, EAEC 
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and EHEC and qnrS  but not qnrA and qnrC in 
ETEC, EIEC, EAEC and EHEC pathotypes (21).  
The marked genome plasticity of diarrheagenic 
E. coli accelerates the adaptation of these 
pathotypes to antibiotic environment (24, 26). 
This allow emergence of strains displaying 
unique phenotypic and genotypic antimicrobial 
resistance patterns under selection pressure of 
antibiotics (24, 26).  Taken together, ETEC is a 
reservoir of antibiotic resistant gene which can 
be horizontally transferred to other diarrheagenic 
E. coli pathotypes among diarrheic children in 
Kenya. Therefore, it is imperative to develop 
strategies to control the spread of resistant 
strains.  
It is important to note that the present study 
had limitations. Sources of these antimicrobial 
resistant genes were not investigated. Study 
participants were recruited within the hospital; 
hence, the prevalence of phenotypic and 
genotypic antimicrobial resistance rates does not 
represent community prevalence. Due to 
financial constraints, we were not able to study 
more antibiotics and antimicrobial resistant 
genes than what we have done, even though 
multiple genes can confer resistance to 
antibiotics. Also, we did not find the association 
between phenotypic and genotypic resistance.  
We observed that DEC is highly resistant to 
ampicillin, streptomycin, gentamycin, 
ciprofloxacin, chloramphenicol and tetracycline 
and the resistance is driven by antimicrobial 
resistant genes. ETEC and EAEC play an 
important role as a potential reservoir of these 
antibiotic resistant genes, thus illustrating the 
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